Genetic Technologies Price to Free Cash Flow Ratio 2006-2021 | GENE

Historical price to free cash flow ratio values for Genetic Technologies (GENE) since 2006. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Genetic Technologies Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2021-10-15 3.02 inf
2021-06-30 4.25 0 0.00
2020-06-30 2.28 0 0.00
2019-12-31 1.99 0 0.00
2019-06-30 2.36 0 0.00
2018-12-31 2.19 0 0.00
2018-06-30 3.96 0 0.00
2017-12-31 4.64 0 0.00
2017-06-30 3.60 0 0.00
2016-12-31 4.32 0 0.00
2016-06-30 8.36 0 0.00
2015-12-31 10.72 0 0.00
2015-06-30 12.16 0 0.00
2014-12-31 7.70 0 0.00
2014-06-30 21.20 0 0.00
2013-12-31 28.60 0 0.00
2013-06-30 46.50 0 0.00
2012-12-31 43.60 0 0.00
2012-06-30 73.00 0 0.00
2011-12-31 60.60 0 0.00
2011-06-30 138.40 0 0.00
2010-12-31 21.10 0 0.00
2010-06-30 19.20 0 0.00
2009-12-31 23.00 0 0.00
2009-06-30 27.40 0 0.00
2008-12-31 21.00 0 0.00
2008-06-30 49.00 0 0.00
2007-12-31 80.20 0 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.046B $0.000B
Genetic Technologies was the first company in the world to recognize important new applications for `non-coding` DNA (DeoxyriboNucleic Acid). The Company has since been granted patents securing intellectual property rights for particular uses of non-coding DNA in genetic analysis and gene mapping across all genes in all multicellular species.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.683B 8.63
Bio-Rad Laboratories (BIO.B) United States $21.975B 46.83
QIAGEN (QGEN) Netherlands $11.773B 19.94
Biohaven Pharmaceutical Holding (BHVN) United States $8.738B 0.00
Emergent Biosolutions (EBS) United States $2.722B 6.57
Arcus Biosciences (RCUS) United States $2.455B 0.00
Myovant Sciences (MYOV) United Kingdom $1.915B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.755B 0.00
Zymeworks (ZYME) Canada $1.208B 0.00
Ambrx Biopharma (AMAM) United States $0.470B 0.00
SQZ Biotechnologies (SQZ) United States $0.342B 0.00
Enzo Biochem (ENZ) United States $0.183B 18.00